Welcome, you can refine the programme by selecting an area of interest below:
  • Full Programme
  • Day 1
  • Day 2
  • Day 3
  • Show All
  • Process & performance improvement
  • Regulatory compliance
  • Engineering, facilities & technology
  • Supply chain integration

DAY 1, 1 December 2014

12:50-13:00
13:00-13:30
keynote

Nurturing a high-performance culture: the critical contribution and stability of senior talent

Helen is a key contributor in the success of Lake Region Medical guiding them towards becoming a bronze SHINGO prize winning company

  • Creating a dynamic company - actively encouraging individuals and giving support to apply knowledge in a smarter way and to come up with creative, well-reasoned solutions
  • Attracting the best talent - appealing to a work-force from over 30 different countries
  • Implementing high potential and talent management programmes - develop and grow the most promising management of the future

Helen Barry
HR Director
Lake Region Medical
Ireland

13:30-14:00
keynote

Launch of Operational Excellence program in March 2014

Frédéric has been a board member for the Swiss Society of Industrial Pharmacists since May 2013, representing the industrial pharmacists as well as supporting and awarding outstanding work in the industry

  • Top down approach with first step: Training (of 80% of Site staff); 8 waste and 5 S deployement
  • Implementation of Visual management on shop floor and Set a management Cockpit across function
  • Value stream Map analysis- identification of main saving potential
  • Set KPI and launch Action plan on main potential saving
  • Track and report saving (reduction of deviation, Improvement of documentation quality; reduction of Throughput Time)

Frédéric Zwahlen
Vice President Supply Chain
Vifor SA
Switzerland

14:30-14:35
14:35-15:05
process & performance improvement

Eliminating the end-product batch sterility test of parenteral products and other pharmaceutical dosage forms through filing process assurance

  • Reducing quality assessment to one day to ship product immediately through validation processes
  • Designing quality into the product, monitoring the manufacturing processes, and controlling the quality of intermediates and finished products in real-time to reduce timelines
  • Incorporating PAT into these stages for real-time release of pharmaceutical dosage forms, by preventing the need for end-product batch testing
  • Advancing PAT technology to monitor manufacturing to enable quality control of the intermediates and finished products, allowing for their release in real-time

Guenaelle Piou
Lean Coach
Astrazeneca
Sweden

regulatory compliance

Updating systems efficiently with assurances throughout the lifecycle of the product

Michael is the lead for the review and improvement of the Medicine Authority's document storage system and facilities project which contributed to them achieving ISO 9001 certification

  • Breaking the tradition - how to get regulators on board when replacing testing with improved equipment
  • What exactly the regulator wants to see in order to pass the audit first time round
  • Exploring the future of audits from ‘tick-box’ to other measures of effectiveness that ensure quality control and satisfy regulatory demands

 

Michael Chetcuti
Quality Assessor
Malta Medicines Authority
Malta

engineering, facilities & technology

Maintaining exacting particulate levels through validation to ensure quality of product

Matthew has had several publications to his credit in international journals such as the flagship EMBO journal in 2002 to The Journal of Biological Chemistry in 2007, showcasing his compelling research

  • Ensuring clean room is sealed correctly and pressurised properly using the latest technological advances
  • Guaranteeing air quality through in-situ moulded air-ducts to ensure low-particulate levels
  • Validating clean rooms with computer systems meeting the CFR 21 Part 11 to meet the FDA’s accepted data formats and ensure maintenance throughout life of room

Matthew Sanders
Director, Process Architecture Improvement
GSK
Belgium

supply chain integration

Building transparency and traceability into the global supply chain by breaking down silos to reduce costs and improve customer service

Professor Constantin is a consecutive academic award winner for best journal reviewer for reviews of the Journal of Operations Management in 2012 and 2013 as well as the Journal of Supply Chain Management in 2012

  • Incorporating operational excellence into the supply chain from API production or procurement to customer delivery to shorten timelines
  • Optimising costs by synchronising the supply chain and logistical network to create an integrated, all-encompassing manufacturing system
  • Creating a lean supply chain to drive out waste and improve efficiency, to not only reduce costs, but also improve flexibility and productivity to enhance customer and brand satisfaction

Prof. Dr. Constantin Blome
GSK Vaccines Chair in Strategic Sourcing and Procurement
Université catholique de Louvain
Belgium

15:05-15:10
15:10-15:40
workshop


workshop


workshop

Gain total control over your extended supply chain through integrated messaging, applications, and data analytics across your network of collaborating and trading partners

  • Frictionless Commerce – Share information and transact seamlessly across your global trading partner network
  • Clear Visibility – Answer key questions; “where are my materials?”, “was my booking confirmed?”,  “when did the product arrive at customer?”
  • Market Driven – Build outside-in flexibility supply that quickly responds to external drivers and disparate demands
  • ERP Agnostic – Get unstuck – a ‘Come-As-You-Are’ approach removes traditional integration and collaboration  barriers
  • Highly Scalable and Secure – Powered by latest generation Infrastructure and Platform as a Service technologies (IaaS and PaaS).  The ‘Network Effect’ maximizes benefits and accelerates value from key supply chain functions

 

Robert Nientker
Senior Sales Executive
Elemica
Netherlands

15:40-16:35
16:35-17:05
process & performance improvement

Integrating Lean and Six Sigma into all aspects of daily activities to improve efficiency by altering description emphasis

Deirdre has played a pivotal role in ensuring the successful implementation of APEX (Amgen Process Excellence) regime which is now being rolled out across other sites to replicate this process improvement globally

  • Transforming a programme to a culture by amending wording to reflect the day-in, day-out efficient routine
  • Re-branding improvement programmes as need-based systems where a lacking is identified and tools deployed in the most efficient manner
  • Developing a work-force that are capable of acting proficiently, using Lean and Six Sigma, but are unaware of this complete integration

Deirdre Cooney
Director Operational Excellence
Amgen
Ireland

regulatory compliance

Achieving incorporated QbD principles through a combination of innovative, robust process analytics, model-predictive control and flexible automation

  • Fully engaging with IT stakeholders and data quality from the offset as full QbD starts from a comprehensive control strategy of raw materials and cell banks
  • Reducing timelines through an integrated centralised data management concept so drugs pass through the FDA filing processes significantly faster
  • Understanding the business case for a QbD drug – examining the longer term financial savings

Dr Bhupinder Singh Bhoop
Dean Faculty of Pharmaceutical Sciences
Education Institution
India

engineering, facilities & technology

Taking a risk-based approach to cross-contamination by overcoming the technological equipment challenges to manufacture without product exposure and meet the new EU GMP Chapters 3 and 5 guidelines

  • Preventing API cross-contamination in finished products through specialised air handling equipment and processing equipment that ensure required exposure control by identifying reliable suppliers
  • Overcoming and determining process risk through process proximity analysis and separating manufacturing areas into zones assigned a colour and number to allow for easy identification
  • Identifying the greatest potential source of containment by measuring manufacturing scale, frequency of production and dosing regime on a regular basis to reduce risk of cross-contamination
  • Developing a successful and robust cleaning validation programme from raw materials to final product flow to prevent contamination and pass audits


supply chain integration

Successfully implementing a European database in order ensure serialisation to the point of dispensation

  • Clarifying the requirements in order to develop a transparent supply chain and reduce timelines through end-to-end optimisation
  • Ensuring supply chain security cost-effectively by encoding barcodes with a product identifier, serial number, batch number and expiry date, using appropriate Application Identifiers
  • Enabling traceability within the EU and interoperability across other sectors using a Global Trade Item Number, to break down trade barriers and ensure patient care


17:05-17:10
17:10-17:40
keynote

How Lundbeck encouraged and inspired the organisation and gradually transformed it to a Lean culture 

Christian has helped drive Lundbeck towards winning a SHINGO silver medallion with his lean transformation initiative

  • How leadership development was utilised to build the Lean culture and the right leadership behaviour
  • How Lundbeck drive the principles of operational excellence in to the organisation and the minds and harts of the employees
  • Lundbeck was recognized with a SHINGO Silver Medallion in 2012 as the first European company and the first pharmaceutical company globally.

Christian Houborg
Vice President, Service and Technical Operations and Lean
Lundbeck
Denmark

17:40-18:10
18:10-18:20

DAY 2, 2 December 2014

08:00-08:45
keynote

Breakfast Brefing


08:50-09:00
09:00-09:30
keynote

Predicting the regulatory landscape over the next five years

Dr Chidwick is a key advisory committee member at the European Medicines Agency (EMEA) for guideline drafting and for the European Directorate for the Quality of Medicines (EDQM)

  • Will the trend for increasing regulations continue despite rising costs?
  • Overcoming the challenges of rising costs and increased regulations to remain competitive
  • Developing a robust communication strategy between pharma companies and regulatory bodies

Dr Keith Chidwick
Pharmaceutical Assessor
MHRA

09:30-10:00
keynote-think tank

Uniting management mind-sets for external success by taking a holistic approach to business

(An interactive panel discussion focusing on thought provoking challenges being led by the speaker. Opportunity to have the audience involved by posing challeges or tasks to be completed as a group)

  • Streamlining the organisational structure and therefore management structure to maximise organisational effectiveness
  • Revolutionising operational planning, development and implementation for higher investment return
  • Developing a world-class manufacturing process by re-strategising management for flexibility and responsiveness


10:00-11:20
11:20-11:50
process & performance improvement

Building a culture of continuous improvement by rethinking operational excellence as an incremental, every-day, every-person process for incremental improvements at every stage

Victor’s formidable leadership qualities has enabled him to transform company culture to create thriving businesses

  • Creating sustainable improvement by increasing collaboration and partnerships between operations and quality to build a quality assurance presence on the shop floor, ensuring compliance
  • Visualising flow of Gemba walk to employees for identification of normal and abnormal flow to increase right-first-time performance in batch records
  • Up-skilling shop floor personnel in their understanding and performance of cGMP/compliance through coaching and mentoring so QA personnel and operations staff work as partners

Victor Torres
Global Engineering Director
Baxter
France

regulatory compliance

Improving business and manufacturing performance by incorporating Six Sigma, Lean and Kaizen from the initial facility design

  • Using Six Sigma as a data-centred process improvement strategy to build quality into processes to avoid complications
  • Transforming ‘good’ product quality of 3.5 sigma to ‘virtual perfection’ of 5.5 sigma by incorporating Lean as a fundamental strategy, not an added programme
  • Utilising Kaizen to accelerate growth and reduce costs by quickly implementing and making changes to specific processes with defects


engineering, facilities & technology

A step-by-step guide to ensure that procured equipment meets qualifications and regulatory demands

  • Developing a Supplier Quality Standard Agreement to outline requirements from suppliers to ensure defect prevention and the continuous developments of quality into products
  • Specifying the requirements of a comprehensive quality system to ensure the supplier has measurable and accountable quality objectives
  • Outlining expectations on suppliers to develop and maintain a management system to assure consistent conformance of their products to denoted quality and cost requirements


supply chain integration

Developing a complete serialisation programme that incorporates both local and global standards to ensure full supply chain ownership

Erik has proven success in profitability improvement through cost reduction, streamlining business processes and innovation and business-growth strategies

  • Guaranteeing global track and trace compliance for secure access to market growth and product integrity through cloud based network platforms
  • Introducing serialisation into the supply chain right first time by identifying the correct production line equipment supplier with specialised technology and capabilities through adaptability assessments
  • Managing the wide global variation and unpredictability by approaching serialisation requirements as a business strategy that incorporates packaging, IT, brand protection and supply chain operations

Erik Dam
Global Supply Strategies
Bayer
France

11:50-11:55
11:55-12:25
workshop

Identifying facility bottlenecks within production

  • Highlighting the equipment/machinery that is holding back the facility's operations
  • Showcasing any equipment that has excess capacity that can be efficiently utilised


workshop


workshop

Implementing improvements using QFD strategies

  • Realising the true potential of QFD as a functional precursor to QbD
  • Priortising the reduction of process complexity in highlighting discrepancies


12:25-12:30
12:30-13:00
panel discussion
process & performance improvement

panel discussion
regulatory compliance

Panellists include:

Ciprian is passionate about optimising process techniques and delivering open innovation strategies throughout the entire supply chain

Ciprian Florea
Global Head, Innovation, TechOps
Novartis Consumer Health
Switzerland

panel discussion
engineering, facilities & technology

13:00-14:30
14:30-15:00
process & performance improvement

Creating a trusted, credible and respected organisation through employee surveys and activity programmes

  • Developing strategies that build employee engagement into day-to-day business operations and workplace culture to ensure long-term results
  • Creating employee feedback systems to drive high workplace satisfaction and increase productivity while delivering cost-efficiencies
  • Improving workforce productivity by managing talent and retaining top performers while controlling labour costs through low staff-turnover

Roni Dattani
SixSigma Black Belt Lead
CSL Behring
Australia

regulatory compliance

Guaranteeing validation robustness throughout the manufacturing process through a repeatable system to ensure compliancy requirements

Thurloch is a fountain of knowledge in the world of quality management with over 30 years’ experience in the pharmaceutical industry

  • Measuring and evaluating process stability and process capability in order to meet regulatory requirements and guarantee quality
  • Meeting the GAMP guidelines for computer validation and 21 CFR Part 11 for electronic records to ensure integrity and reliability of records
  • Building validation as part of the complete life cycle of a computer system in order to satisfy Annex 11 of the European GMP directive

Thurloch O'Criodain
Global Lead Quality Steward
Novartis
Switzerland

engineering, facilities & technology

Increasing production whilst ensuring compliance and minimising safety risks by incorporating early risk assessment procedures of equipment sterility

  • Efficiently increasing plant production capacity whilst minimising safety risks and maintaining quality through low cross-contamination risks
  • Expanding manufacturing capacity to develop specialist new capabilities to meet the growing demands of personalised medicine
  • Managing multiple mid-sized upgrade projects whilst maintaining smooth running of production, regulatory compliance and with low safety risks


supply chain integration

Lowering process costs and improving customer service through improved efficiency of supply chain management

Murillo is a renowned author of business books including ‘Strategic Sourcing – Suppliers are from Mars, Customers are from Venus’ and ‘Project Management – Headstart’

  • Developing visibility into the top-line perspective by using the ERP system to streamline operations for efficient quality assurance at every stage to reduce time-to-market
  • Creating efficiency programs that not only yield results on cost and inventory across key parts of the supply chain, but also to the bottom line through end-to-end optimisation
  • Improving transparency to manage the supply chain on an end-to-end basis breaking down the silo caused by the split in distribution chain between technical operations and commercial functions

Murillo Xavier
Strategic Development, Industry Standard Servers (ISS) Supply chain
HP
US

15:00-15:05
15:05-15:35
workshop

  • Prioritising team engagement and understanding

Realising that lean in R&D can mimic but cannot not mirror manufacturing principles

Maximising process understanding and mapping to limit waste, time and cost


workshop

New online technology for high sensitivity broad dynamic range assays of complex in-process material

  • Utilising PAT to improve recovery, ensure final product quality and yield, and to achieve business objectives
  • Achieving real-time LC analysis of complex inprocess samples in the production environment
  • Efficient design of an effective QbD strategy in manufacturing


workshop

Leveraging the oppertunities and challenges of using the latest IT systems 

  • Calculating true cost saving figures before investment
  • Overcoming regulatory and compliance hurdles
  • Planning for massive resource, capital and personnel investment to reap the rewards of globalisation in the long term


15:35-16:35
16:35-17:05
process & performance improvement

Reducing variation by 60% and improving average OEE by nearly 20 points within 16 weeks

Carsten has revamped the working structure at Novo Nordisk by increasing the production capacity through the introduction of lean processes

  • Integrating performance management, leadership behaviour development and workforce development with lean principles to improve final assembly performance
  • Reintegration of the Performance Improvement Cycle through bottom-up confirmation and top-down prioritisation
  • Creating value from failure: how to assess an unsuccessful update to gain value from the learning cycle


Carsten Thorngreen
Director, Pre-Assembly Production in Device Manufacturing & Sourcing
Novo Nordisk
Denmark

Morten Søvndahl Johannessen
Lean Partner, Pre-Assembly Production in Device Manufacturing & Sourcing
Novo Nordisk
Denmark

Tim Schwarting
Program/Project Manager, Device Manufacturing & Development, LSS Black Belt
Novo Nordisk
Denmark

engineering, facilities & technology

Ensuring engineering facilities meet the required standards for containment equipment, room cleanliness and perimeter monitoring to reduce risk of cross-contamination

  • Categorising drug substances according to their potency using occupational exposure limits and bands, in order to implement a thorough risk assessment
  • Increasing the efficiency of manufacturing highly-potent APIs to reduce timelines by incorporating the latest engineering technologies
  • Protecting employees and the product through extra containment barriers, including personal protective equipment and proper training on operation and maintenance of isolation equipment


supply chain integration

Managing the product code data centrally to minimise the risk of counterfeiting by ensuring product security electronically, integrating CFR 21 Part 11

Ryan is the 2012 Award winner for Pharma Supply Chain Officer of the Year at 6th Express, Logistics and Supply Chain Conclave (ELSC)

  • Ensuring one product code across the whole life-cycle of the drug internally and externally by managing the data centrally to reduce risks in counterfeiting
  • Improving productivity and efficiency through automation by minimising the maintenance and retention of paper documentation
  • Increasing speed of identification and removal of counterfeit and recalled drugs by implementing a track and trace system using a data matrix

Ryan Viegas
VP supply Chain
Actavis
India

17:05-17:10
17:10-17:40
keynote

How does big data underpin the economy and how should we harness its potential?

  • Google Flu Trends – adding theory to a data-rich model to go beyond correlation to reach causation
  • Size is not everything – overcoming the challenges of sample error and sample bias for an accurate data pool
  • Targeting customers – what can the pharmaceutical industry learn from customer insight programmes?


17:40-18:10
keynote

Driving continuous improvement though the company vision to build a highly engaged and adaptable workforce

 

  • Integrating VSMs into the CII process to create a scheduled pipeline of products that reduces costs
  • Employing the CII process to map the extended supply chain, from tier two raw material suppliers, through to primary and secondary distribution centres
  • Making the customer central by running a customer connection programme on site

Franck Demarest
Lead
Rexam
France

18:10-18:20

DAY 3, 3 December 2014

08:00-08:50
08:50-09:00
09:00-09:30
keynote

Protecting drug products by forming partnerships and controlling entry into the market

  • Assessing the impact of generics in the market place and the strategies to stay profitable without patent protection
  • Forming partnerships with generic providers for early, controlled release of the drug, whilst maintaining IP security
  • Maintaining profitability by restricting whole market access to develop majority market share


09:30-10:00
keynote

Assessing the trend for product volume to reduce whilst number of products increases

  • Addressing the increasing pipeline in order to maintain profitability long-term
  • Balancing the increasing costly quality requirements with decreasing margins
  • Delivering the complexity in the supply chain caused by the change in model


10:00-11:20
11:20-11:50
process & performance improvement

Utilising data-driven process analysis to measure the soft skill key success factors required for shop floor performance improvements

  • Driving towards a strong culture of continuous improvement by using visual metric to improve communication
  • Employing visual control mechanisms, including Andon Boards, to address current quality issues and provide immediate, highly-visible process feedback
  • Increasing reaction speed through real-time process integration for time-optimised and structured visualisation of production data from various shop-floor systems across all plants

Marcel de Matas
Principle Scientist Product Design & Innovation
Astrazeneca
UK

regulatory compliance

Incorporating reduced requalifications in schedule whilst satisfying external inspectors through the risk assessment of the change procedure

  • Clarifying Annex 15 of the EU GMP guidelines in order to assess extent of requalifications required
  • Developing thorough analysis of calibration, verification and maintenance results in order to satisfy lower frequency requirements
  • Justifying reduced requalification to regulators after changes by developing a more complete and complex risk assessment 


engineering, facilities & technology

Examining the benefits of Cilag’s System Based Ownership Concept (SBOC), including reduced accidents without a costs and insufficient separate EHS group

  • Interpreting Johnson & Johnson’s Management Action Awareness Reporting System into separate system owners for each EHS aspect, to execute the system across a workforce of 12,000
  • Developing a matrix organisational system so EHS penetrates into the full organisation, spreading responsibility across the shop floor to lower accident rates by x%
  • Incorporating EHS as an aspect of daily jobs, using SBOC, to successfully benchmark results and pass audits


supply chain integration

Optimising complexity in supply chain decisions by implementing complex adaptive system (CAS) modelling to counteract the increasing product pipeline

  • Quantifying supply chain complexity to stop reacting intuitively and develop tools and methods in order to make complexity-optimised decisions
  • Interpreting the supply chain as a CAS, with a large number of interacting and evolving agents who adapt and learn, in order to solve complexity dilemmas
  • Creating a forecasting-improvement initiative to tie timings and frequency to decision needs to reduce costs by up to 10%

Claudio Camposeo
Global Purchasing Head
Boehringer-Ingelheim
Germany

11:50-11:55
11:55-12:25
workshop

Supplier & partner relationship management

  • Efficiently measuring & communicating performance expectations and results
  • Prioritising mutually agreed-upin standards over internal biases
  • Ensuring a heightened understanding of performance & potntial improvements


workshop

How can pharma manufacturers meet regulators putative demands amidst price pressures, regulatory changes and healthcare reforms?

  • Understanding the most significant regulatory trends  impacting production
  • Improving statistical data analysis and understanding to prepare for increasingly skilled regulatory questions and deeper technical investigations
  • How are the most successful pharma companies dealing with price pressures, low cost production vs. innovation and total cost reduction of patient treatments?


workshop

Understanding the root-causes of equipment stoppages

  • Rebuilding maintenance and production planning
  • Training Operations and Maintenance teams
  • Using the right equipment with the right product using a deep process engineering approach
  • Implementing OEE and its analysis from the beginning


workshop

Does globalisation bring additional risk or new opportunities to your supply chain?

  • Enhancing global flow of goods, information and capital
  • Addressing energy concerns in the supply chain
  • Minimising supply chain risk through global sourcing
  • How is consumer growth in emerging markets affecting the supply chain?


12:25-12:30
12:30-13:30
13:30-14:00
panel discussion
process & performance improvement

panel discussion
regulatory compliance

Panellists include:

Jochen has been directly involved in the new development project at Novartis Vaccines with the opening of the new Marburg site in June 2014

Jochen Reutter
Site Head and Managing Director
Novartis
Germany

panel discussion
engineering, facilities & technology

panel discussion
supply chain integration

14:00-14:05
14:05-14:35
process & performance improvement

Cost savings through reduced manning and compliance computer validation systems by employing Process Analytical Technology and Advanced Process Control

  • Ensuring compliance with safety considerations, meeting the ISPE’s GAMP guidelines by using PAT for identification, determination and management for all critical sources of variability
  • Converting data using APC to allow information to feed-back into the process in real-time to reduce the risk of product recall
  • Optimising decision speed using APC to create a visualisation system that requires minimal operator staffing, reducing staff costs whilst maintaining product quality


regulatory compliance

Ensuring employees are aptly qualified in minimum time to satisfy regulators and decrease risk of warning letters

  • Identifying training needs by allocating employees into organisational or functional groups to ensure tailored training across large staff numbers
  • Managing adequate resources for the technical and GxP training of staff by regularly reporting on the ratio of planned training to number of training
  • Implementing a software control system to monitor the GMP compliance status, identify training needs of employees and satisfy documentation requirements
  • Ensuring transparency of training status of employees through automatic periodic reports to guarantee high status of compliance


engineering, facilities & technology

Assessing and eliminating risk through a robust and repeatable mitigation plan and validation strategy

  • Shortening the validation life-cycle in order to start regulatory approval faster by incorporating the latest technology in automated camera-based inspection systems
  • Transferring critical process parameters to the vendor early in order to hold tolerances within defined specifications and therefore reduce overall costs
  • Demonstrating through documents compliant to FDA CRF Title 21 standards the consistency of the system


supply chain integration

From planning, evaluation and execution - identifying potentially adverse process issues early to ensure success proactively

Julian Amey is the co-Author of a recent study from January 2011 into Supply Chain Management organisations in the process industries

  • Identifying the correct suppliers to match business needs and integrate vendor into management structure to ensure alignment of long-term objectives
  • Eliminating risk through a mitigation plan that identifies and defines critical process parameters and critical quality attributes

Julian Amey
Principal Fellow & Acting Director of Professional & Executive Programmes, Warwick Manufacturing Group
University of Warwick
UK

14:35-14:40
14:40-15:10
keynote- think tank

Aligning manufacturing strategies pre-, during and post-merger to ensure long-term sustainability

(An interactive panel discussion focusing on thought provoking challenges being led by the speaker. Opportunity to have the audience involved by posing challeges or tasks to be completed as a group)

  • Assessing the trend and impact of big mergers and acquisitions on the pharma industry
  • Identifying essential components at each stage of the post-merger integration
  • Retaining long-term change management after the formal merger to monitor performance against business goals and objectives to ensure success


15:10-15:40
keynote

What is the future of the use of data and technology in the pharmaceutical industry?

Joaquín is responsible for helping to introduce a supplier management portal on the Decisyon 360 platform helping company procurement managers improve supply chain reliability, quality and reduce risk


  • Shop-floor data metrics – the impact of hand-held devices at the manufacturing stage
  • Connecting patients to the manufacturers in order to assess supply and demand in real-time
  • Exploring the potential impacts this will have on the pharma manufacturing industry

Joaquín Santos Benito
Senior Director External Supply Integration
Janssen
Spain

15:40-15:50